Cover Image

Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis

Background Direct oral anticoagulants (DOACs) have demonstrated clinical benefits and better patient adherence over low-molecular-weight heparin (LMWH) in treating patients with cancer-associated venous thrombosis (CAT). We aimed to compare the cost-effectiveness of DOACs against LMWH in patients wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Kang (Author), Kuan Peng (Author), Vincent K.C. Yan (Author), Daoud Al-Badriyeh (Author), Shing Fung Lee (Author), Hei Hang Edmund Yiu (Author), Yue Wei (Author), Silvia T. H. Li (Author), Xuxiao Ye (Author), Aya El Helali (Author), Ka On Lam (Author), Victor H. F. Lee (Author), Ian C. K. Wong (Author), Esther W. Chan (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
by: Alex C Spyropoulos, et al.
Published: (2008)

Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review
by: Ke Feng, et al.
Published: (2023)

Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report
by: Mia Gonzales MD, MPH, et al.
Published: (2019)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023)

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
by: Razia Sultana, et al.
Published: (2024)

Anticoagulants in Pediatric Sinovenous Thrombosis
by: J Gordon Millichap
Published: (2010)

Sinovenous Thrombosis: Anticoagulation Therapy
by: J Gordon Millichap
Published: (1998)

Neutrophil extracellular traps and heparin-induced antibodies contribute to vascular access thrombosis in hemodialysis patients
by: Hoi Woul Lee, et al.
Published: (2021)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
by: Abdel-Razeq H, et al.
Published: (2011)

Effectiveness of anticoagulant therapy using heparin combined with Plavix after Rex shunt
by: JinShan Zhang, et al.
Published: (2024)

Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations
by: I. S. Yavelov, et al.
Published: (2022)

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
by: Lucia Gozzo, et al.
Published: (2020)

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
by: Andre Bredthauer, et al.
Published: (2020)

Direct oral anticoagulants for the treatment of Cancer-Associated Thrombosis
by: Łukasz Ledziński, et al.
Published: (2021)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020)

Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023)

Whether anticoagulation is needed for ovarian vein thrombosis in non-pregnant patient?
by: FengXiang Yao, et al.
Published: (2024)

HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY
by: A. D. Makatsariya, et al.
Published: (2016)

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
by: A. D. Aga, et al.
Published: (2023)

Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment
by: E. S. Kropacheva
Published: (2020)

Calibration and validation of the rabbit model of electrolytic‐mediated arterial thrombosis against the standard‐of‐care anticoagulant apixaban
by: Pancras C. Wong, et al.
Published: (2022)

Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint
by: Ardalan Mohammad-Reza
Published: (2014)

Pharmacology complex compound of pro-gly-pro-leu with heparin: hypoglycemic, fibrinolitic and anticoagulant effects in rats with hyperglycemia
by: T. Yu. Obergan, et al.
Published: (2019)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
by: Shimizu K, et al.
Published: (2018)

Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
by: Edrich T, et al.
Published: (2015)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022)

THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
by: I. S. Daaboul, et al.
Published: (2018)

Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction - Current Recommendations and Future Perspectives
by: Haba Mihai Ștefan Cristian, et al.
Published: (2022)

A China-Based Cost-Effectiveness Analysis of Novel Oral Anticoagulants versus Warfarin in Patients with Left Ventricular Thrombosis
by: Tian S, et al.
Published: (2024)

Does low molecular weight heparin really protect against prosthetic valve thrombosis during pregnancy with strict anti-Xa monitoring?
by: Macit Kalçık, et al.
Published: (2021)

Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest
by: Devon S. McKenzie MD, et al.
Published: (2018)

Management of anticoagulated patients in dentoalveolar surgery: a retrospective study comparing bridging with heparin versus unpaused vitamin K antagonist medication
by: Mayte Buchbender, et al.
Published: (2021)

Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study
by: Anish Keepanasseril, et al.
Published: (2021)

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
by: Dania Ghaziri, et al.
Published: (2023)

Effects of low-molecular-weight heparin and unfractionated heparin on patients with exertional heat stroke with thrombocytopenia: A prospective study
by: Li Cheng, et al.
Published: (2019)

Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches
by: Jason B. Giles, et al.
Published: (2022)

Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study
by: Liu PC, et al.
Published: (2017)

Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China
by: Yue Wu, et al.
Published: (2024)

Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant
by: Charles J. Glueck MD, et al.
Published: (2016)